Home » Market News » DirectorsTalk Highlights » ImmuPharma’s Tim McCarthy delighted with £4.1 million fund raise support
Immupharma Plc

ImmuPharma’s Tim McCarthy delighted with £4.1 million fund raise support

 

Tim McCarthy, Chairman of ImmuPharma PLC (LON:IMM) talks to Proactive Investors about the company’s £4.1 million raise from investors after an oversubscribed placing.

The new cash infusion is to be used to strengthen its balance sheet as negotiations take place with potential commercial partners for its flagship drug, Lupuzor.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.